Amjad Bahnassi, MD
Psychiatry · Worcester, MANPI 1487754974
Payments from drug & device makers
Across 1,514 payments — averaging $232.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$80K
- Alkermes, Inc.$71K
- Otsuka America Pharmaceutical, Inc.$61K
- Johnson & Johnson$43K
- AbbVie$31K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$19K
- plus $47K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$352,093 in reported general payments places this provider in the 95th percentile of 1,431 psychiatry providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Worcester
- Xiaoduo FanWorcester$950K
- Anthony RothschildWorcester$838K
- Rifat SharifWorcester$203K
- Mohamed OchWorcester$45K
- Mark SchlickmanWorcester$41K
- Jean FrazierWorcester$40K
- Lee CohenBoston$7M
- Dyanna DomiliciBoston$5.8M
- Arkadiy StolyarBelmont$3.3M
- Maurizio FavaBoston$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.